Current Rheumatology Reports

, Volume 2, Issue 1, pp 53–61

Glucocorticoid-induced osteoporosis

  • Pauline Boulos
  • George Ioannidis
  • Jonathan D. Adachi
Article

DOI: 10.1007/s11926-996-0069-4

Cite this article as:
Boulos, P., Ioannidis, G. & Adachi, J.D. Curr Rheumatol Rep (2000) 2: 53. doi:10.1007/s11926-996-0069-4

Abstract

This article attempts to evaluate the results of several recently published clinical trials of drugs used in the treatment and prevention of glucocorticoid-induced osteoporosis. Despite our lack of understanding regarding the biological mechanisms that lead to glucocorticoid-induced bone loss, effective therapy has been developed. Bisphosphonates have demonstrated significant treatment benefits and should be considered the therapy of choice for both the treatment and prevention of glucocorticoid-induced osteoporosis.

Copyright information

© Current Science Inc 2000

Authors and Affiliations

  • Pauline Boulos
    • 1
  • George Ioannidis
    • 1
  • Jonathan D. Adachi
    • 1
  1. 1.St. Joseph’s Hospital, McMaster UniversityHamiltonCanada